Medical Robots Market Share, Size and Growth Analysis By 2029

The global market for medical robots is anticipated to reach a staggering US$ 25,443.36 million by 2028, a significant increase from US$ 9,189.70 million in 2022. This growth represents a compound annual growth rate (CAGR) of 18.5% from 2022 to 2028.

Several factors contribute to the expansion of the medical robots market, including the rising number of surgical procedures and an increase in product launches and regulatory approvals. However, the high costs associated with surgical procedures and the installation of robotic systems pose challenges to market growth.

Medical robots are specialized service robots utilized in various healthcare settings to enhance patient care. They alleviate the workload of healthcare professionals, enabling them to dedicate more time to direct patient interaction while streamlining operational processes that enhance efficiency and reduce healthcare costs. These robots serve multiple functions, such as telepresence robots for remote patient care, disinfectant robots aimed at minimizing hospital-acquired infections, and robotic exoskeletons designed for rehabilitation training, which provide external support and assist with muscle training.

In hospital environments, medical robots are employed to transport medications and other sensitive materials. A medical robotic system guarantees precision and is often utilized for minimally invasive procedures that can be controlled remotely. Current systems consist of computer-controlled electromechanical devices that respond to commands from surgeons. The advantages of using robots in medicine are numerous; they can shorten procedure times, reduce hospital stays, lower the risk of surgical site infections, and minimize pain and discomfort. Additionally, these systems facilitate quicker recovery times and decrease blood loss and the need for transfusions.

Nanorobots are emerging as a crucial element in biomedicine, particularly in the treatment of conditions such as cancer and cerebral aneurysms, as well as in procedures like kidney stone removal and rectifying defects in DNA structures. The latest advancements in medical technology and therapeutic tools have significantly improved cancer treatment outcomes. Effective drug delivery is vital to mitigate the side effects associated with chemotherapy. Nanorobots equipped with implanted chemical biosensors can detect tumor cells at early stages of cancer development within a patient?s body. Nanosensors are employed to assess the intensity of E-cadherin signals, which are crucial in identifying cancerous cells. Traditional drugs often affect both cancerous and healthy cells, leading to adverse side effects. In contrast, nanorobots can specifically target tumors, thereby avoiding unnecessary clotting and reducing side effects during cancer treatment.

Investment in innovative technological advancements by manufacturers and researchers is on the rise. For example, scientists from Arizona State University, in collaboration with the National Center for Nanoscience and Technology of the Chinese Academy of Sciences, have programmed nanorobots to shrink tumors by cutting off their blood supply. They have also developed the first fully autonomous DNA robotic system aimed at precise drug design and targeted cancer therapy.

The medical robots market is undergoing significant technological transformations that empower companies to create innovative products. Cutting-edge solutions are expected to enhance health outcomes, allowing individuals to lead healthier lives. Leading firms are consolidating their market positions through extensive research and development activities to introduce advanced products. For instance, in December 2021, Inrobics Social Robotics launched an AI-driven robotic device designed to assist in health rehabilitation. Furthermore, in April 2022, SS Innovations unveiled its SSI multi-arm telerobotic surgical assistance system in India, priced between US$ 0.54 million and US$ 0.68 million (INR 40-50 million). Such product launches are expected to bolster market growth during the forecast period.

The global medical robots market is categorized based on product type, application, and end-user. In terms of product segmentation, the market includes surgical robots, rehabilitation robots, non-invasive radiosurgery robots, hospital and pharmacy robots, among others. The surgical robots segment is projected to hold the largest market share throughout the forecast period. Surgical robots are automated, computer-controlled devices designed to assist in the positioning and manipulation of surgical instruments, enabling surgeons to perform intricate procedures with enhanced precision and control.

On the other hand, the rehabilitation robots segment is anticipated to exhibit the highest CAGR during the forecast period. Rehabilitation robotics focuses on enhancing recovery through robotic devices, driven by the increasing demand from the elderly and disabled populations. These robots are optimized to provide effective rehabilitation therapy, offering movement control and reliable measurement, making them invaluable tools for neurologists and therapists addressing neuro-rehabilitation challenges. Rehabilitation robots can be classified into two main categories: actuated robotic limbs and robotic suits, such as exoskeletons, that support affected limbs.

Key sources for this report on the global medical robots market include the World Health Organization (WHO), the International Diabetes Federation (IDF), the National Library of Medicine, and the National Center for Biotechnology Information (NCBI).